ICAD INC
ICADHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $19.6M | $17.3M | $19.8M | $33.6M | $29.7M | $31.3M |
| Operating income | −$6.3M | −$7.7M | −$10.2M | −$10.7M | −$9.4M | −$6.4M |
| Net income | −$5.6M | −$4.8M | −$13.7M | −$11.2M | −$17.6M | −$13.6M |
| Total assets | $37.5M | $41.4M | $51.7M | $62.2M | $55.6M | $41.7M |
| Total liabilities | $8.9M | $8.0M | $16.8M | $15.7M | $25.1M | $36.7M |
| Equity | $28.7M | $33.4M | $34.9M | $46.5M | $30.5M | $5.1M |
| EPS (diluted) | $-0.21 | $-0.19 | $-0.54 | $-0.45 | $-0.80 | $-0.74 |
| Shares out. | 26.5M | 25.4M | 25.2M | 24.9M | 21.2M | 17.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −32.0%
- Net margin
- −28.6%
- Return on equity
- −19.6%
- Return on assets
- −15.0%
- Return on capital (ROCE)
- −20.9%
- Liabilities / assets
- 23.6%
- Debt / equity
- 0.31×
- Book value / share
- $1.08
- Revenue growth (YoY)
- 13.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -18.51distress
- Accruals / assets
- −4.5%clean
- Beneish M-Score
- -2.58normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Goldman Sachs Group IncPassive (13G)Nov 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Jul 15, 2025 | 249,547 | 1.5 | +7.4% |
| Jun 30, 2025 | 232,422 | 1.2 | -13.8% |
| Jun 13, 2025 | 269,602 | 1.0 | -9.1% |
| May 30, 2025 | 296,451 | 1.0 | -25.4% |
| May 15, 2025 | 397,437 | 1.0 | +28.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureJul 17, 2025
- Shareholder voteJul 14, 2025
- Director / officer changeMay 22, 2025
- Results of operationsMay 13, 2025
- Entered a material agreement · Director / officer change · Regulation FD disclosureApr 15, 2025
- Results of operationsMar 19, 2025
- Results of operationsJan 27, 2025
- Results of operationsNov 13, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/ANov 10, 2025
- SCHEDULE 13GAug 12, 2025
- 15-12GNOTICE OF TERMINATIONJul 28, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- EFFECTJul 21, 2025
- 4Jul 17, 2025
- 4Jul 17, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.